Doug Melancon

Doug Melancon is Managing Director at Advent Capital Management, based in New York, where he leads the firm’s global healthcare investment efforts across both equity and fixed income portfolios. His role encompasses portfolio management, healthcare industry research, and the strategic allocation of capital within healthcare-related securities, leveraging over twenty years of sector-specific investment experience.

He specializes in the healthcare sector, with deep expertise in evaluating biopharmaceuticals, medical devices, diagnostics, and healthcare services investments. Melancon brings a proven track record of identifying investable opportunities at the intersection of medical innovation and financial markets, and has been recognized for his skill in distilling complex clinical data into actionable investment insights.

Melancon’s prior roles include Portfolio Manager at Merlin Biomed and Senior Vice President at Weiss, Peck & Greer, where he built expertise in healthcare-focused funds and research-driven portfolio management. He holds a B.S. in Bioengineering and an MBA from the University of Illinois Urbana-Champaign, and an M.D. from the University of Pennsylvania School of Medicine, uniquely positioning him as an expert at the nexus of healthcare, technology, and capital markets.